Teva Pharmaceutical beats first-quarter profit estimates on branded drugs demand
Teva Pharmaceutical beats first-quarter profit estimates on branded drugs demand
ReutersWed, April 29, 2026 at 11:05 AM UTC
0
A man walks past the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017. REUTERS/Ammar Awad
April 29 (Reuters) - Teva Pharmaceutical Industries beat Wall Street estimates for first-quarter profit on Wednesday, helped by sales of its branded medicines.
Advertisement
Israel-based Teva, the world's largest generics drugmaker, earned adjusted profit of 53 cents per share, compared with analysts' estimate of 48 cents per share, according to data compiled by LSEG.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Pooja Desai)
Source: “AOL Money”
